Naltrexone blocks the mu-opioid receptor, so even the partial signal Buprenorphine provides is removed.
Buprenorphine produces a submaximal response at the mu-opioid receptor. Naltrexone produces none and competes for the same site, so it takes away even that partial signal.
Given together they work against whatever each was started for. If both are genuinely needed, expect less of Buprenorphine’s effect than its dose would suggest.
This is a pharmacodynamic interaction. Neither drug changes the other’s concentration, so a level, an AUC estimate or a genotype looks entirely normal while the clinical effect is blunted.
The direction can be the useful one. The same opposition is what makes a reversal agent, an antidote or a planned antagonist work.



The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

